Business

Lupin#39;s Pithampur facility may face regulatory action, says USFDA

Lupin#39;s Pithampur facility may face regulatory action, says USFDA The Mumbai-based drugmaker, however, said it does not believe that the classification would have an impact on disruption of supplies or the existing revenues from operations of this facility.

from Moneycontrol Business News
Read The Rest:moneycontrol...

Realted Posts